#540 Hotcakes: Varenicline by mail for smoking cessation, anticoagulation for intermediate risk AF, CAC score plus PREVENT, blood testing for CRC, oral PCSK9 inhibitors, and more

Join us as we review recent practice-changing articles on Varenicline by mail for smoking cessation, anticoagulation for intermediate risk AF, CAC scores plus PREVENT for ASCVD risk stratification, blood testing for CRC, a new oral PCSK9 inhibitor, and more. Fill your brain hole with a delicious stack of hotcakes! Featuring Paul Williams (@PaulNWilliamz), Rahul Ganatra (@rbganatra), and Matt Watto (@doctorwatto).Claim CME for this episode at curbsiders.vcuhealth.org!Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CMECredits Written and Hosted by: Rahul Ganatra MD, MPH; Paul Williams, MD, FACP, Matthew Watto MD, FACP Cover Art: Rahul Ganatra, MD, MPH Reviewer: Sai S  Achi, MD, MBA, FACP Technical Production: Pod Paste Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Show Segments Intro, disclaimer Varenicline by mail for smoking cessation Anticoagulation for intermediate-risk AF CAC scores added to PREVENT for ASCVD Blood testing for colorectal cancer Oral PCSK9 inhibitor, negative results for pelacarsan and ziltivekimab  Outro Sponsor: MasterClassGet at least 15% off any annual membership at masterclass.com/CURB. Sponsor: The Permanente Medical GroupInterested physicians can visit  to get more information and RSVP at northerncalifornia.permanente.orgSponsor: UpToDateVisit www.uptodate.com/cme for CME details. Curbsiders listeners can get 10% off UpToDate packages with code CURB4Sponsor: Panacea LegalVisit Panacea.Legal/curb to schedule your free consultation.